|
|
Suppliers for
Everolimus
|
Properties | CAS |
159351-69-6 | Formula |
C53H83NO14 |
|
|
25 Registered suppliers
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Molecular Formula: C53H83NO14 Molecular Weight: 958.232 Hazard Symbols: T,Xn,F UN Number: UN 1648 3 / PGII WGKGermany: 2 HS Code: 29349990
More details are to be found here
Molecular Formula: C53H83NO14 Molecular Weight: 958.232 Hazard Symbols: T,Xn,F UN Number: UN 1648 3 / PGII WGKGermany: 2 HS Code: 29349990
More details are to be found here
Molecular Formula: C53H83NO14 Molecular Weight: 958.232 Hazard Symbols: T,Xn,F UN Number: UN 1648 3 / PGII WGKGermany: 2 HS Code: 29349990
More details are to be found here
Residual solvents II Ethylene glycol NMT 620 ppm
Water NMT 2.0% 0.8% Residual on ignition NMT 1.0%
Heavy metals NMT 20 ppm Conforms
Assay 98%~102.0% (calculated on andydrous and BHT free ) 100.4%
Crystal form Amorphous Amorphous
Residual solvents II Ethylene glycol NMT 620 ppm
Water NMT 2.0% 0.8% Residual on ignition NMT 1.0%
Heavy metals NMT 20 ppm Conforms
Assay 98%~102.0% (calculated on andydrous and BHT free ) 100.4%
Crystal form Amorphous Amorphous
More details are to be found here
More details are to be found here
More details are to be found here
Description : Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) with an immunosuppressive activity which is comparable to that of rapamycin. It inhibits cytokine-mediated lymphocyte proliferation. Everolimus can be used as an immunosuppressant in the treatment of renal cell cancer and other cancers. - Molecular Weight :958.24
- Boiling Point :998.7±75.0°C at 760 mmHg
- Melting Point :107-113°C
- Purity :> 98%
Molecular Formula : C53H83NO14 Canonical SMILES : CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC InChI : InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 InChIKey : HKVAMNSJSFKALM-GKUWKFKPSA-N Solubility : Soluble in ethanol, methanol, DMF, DMSO Appearance : Off-white to Pale Yellow Solid Application : immunosuppressant Storage : Store at -20°C Synonyms : RAD-001; RAD001; RAD 001; Afinitor; Certican; Zortress; RAD001; SDZ-RAD
More details are to be found here
Description : Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) with an immunosuppressive activity which is comparable to that of rapamycin. It inhibits cytokine-mediated lymphocyte proliferation. Everolimus can be used as an immunosuppressant in the treatment of renal cell cancer and other cancers. - Molecular Weight :958.24
- Boiling Point :998.7±75.0°C at 760 mmHg
- Melting Point :107-113°C
- Purity :> 98%
Molecular Formula : C53H83NO14 Canonical SMILES : CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC InChI : InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 InChIKey : HKVAMNSJSFKALM-GKUWKFKPSA-N Solubility : Soluble in ethanol, methanol, DMF, DMSO Appearance : Off-white to Pale Yellow Solid Application : immunosuppressant Storage : Store at -20°C Synonyms : RAD-001; RAD001; RAD 001; Afinitor; Certican; Zortress; RAD001; SDZ-RAD
More details are to be found here
Description : Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) with an immunosuppressive activity which is comparable to that of rapamycin. It inhibits cytokine-mediated lymphocyte proliferation. Everolimus can be used as an immunosuppressant in the treatment of renal cell cancer and other cancers. - Molecular Weight :958.24
- Boiling Point :998.7±75.0°C at 760 mmHg
- Melting Point :107-113°C
- Purity :> 98%
Molecular Formula : C53H83NO14 Canonical SMILES : CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC InChI : InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 InChIKey : HKVAMNSJSFKALM-GKUWKFKPSA-N Solubility : Soluble in ethanol, methanol, DMF, DMSO Appearance : Off-white to Pale Yellow Solid Application : immunosuppressant Storage : Store at -20°C Synonyms : RAD-001; RAD001; RAD 001; Afinitor; Certican; Zortress; RAD001; SDZ-RAD
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Purity : 98% Smile code : O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O MDL Number : MFCD00929329 MolFormula : C53H83NO14 MolWeight : 958.2244 Available in stock : 3.968
More details are to be found here
Detailed information on the suppliers of
Everolimus
|
Properties:
... more properties and specification on Everolimus
|
|
Privileged suppliers
Last update 2024-05-23
|